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A B S T R A C T
Purpose: To determine the prevalence of active convulsive epilepsy, seizure frequency and the outcome
of pregnancy amongst a cohort of pregnant women attending antenatal clinic (ANC) at two tertiary
hospitals.
Methods: An observational cohort study conducted at the University of Maiduguri Teaching Hospital and
State Specialist Hospital, Northeast Nigeria. Pregnant women attending antenatal care were screened for
previous history of active convulsive epilepsy, and recruited consecutively according to a speciﬁed
protocol. A standardized questionnaire was administered to record pregnancy history, nature of epilepsy
and treatments received. They were followed-up during the course of the pregnancy based on the ANC
schedule up to delivery. The outcome of pregnancies was recorded.
Results: A total of 7063 pregnant women were screened, of whom 103 (1.46%) subjects had at least a past
history of seizure. Seventy-eight (1.10%) had a past history of seizure(s) from eclampsia and 23 (0.33%)
pregnant subjects recruited were identiﬁed to have active convulsive epilepsy. The unadjusted
prevalence of active convulsive epilepsy in pregnant women was found to be 3.33 per 1000 (95% CI: 2.1–
4.8). Subjects who had a history of head injury and encephalitis were more likely to have seizures during
pregnancy. (P = 0.013 and P = 0.041). Those who had recurrent seizures within the last six months before
recruitment were more likely to have a negative pregnancy outcome (P = 0.043).
Conclusion: Our study found a prevalence of active epilepsy of 3.33 per 1000 among pregnant women,
with about one percent having a past history of seizure from eclampsia.
 2015 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
Contents lists available at ScienceDirect
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jou r nal h o mep age: w ww.els evier . co m/lo c ate /ys eiz1. Introduction
Epilepsy is a common and serious neurological condition
characterized by an enduring predisposition to generate epileptic
seizures with neurobiologic, cognitive, and psychosocial conse-
quences [1,2]. The annual incidence of epilepsy in the developed
countries is about 50–70 cases per 100,000 population and a
prevalence of about 5–10 per 1000. The developing world accounts
for a large percentage of cases with an incidence of 100–190 cases
per 100,000 per year [3]. The lifetime prevalence of epilepsy may
be lower in low- to middle-income countries (Laics), which is
speculated to be due mainly to higher premature mortality [4]. A* Corresponding author. Tel.: +234 447776744507, +234 7032020807.
E-mail address: watilamusa@yahoo.com (M.M. Watila).
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1059-1311/ 2015 British Epilepsy Association. Published by Elsevier Ltd. All rights reNigeria study gave a crude prevalence of epilepsy at 533 per
100,000 [5]. Head trauma, cerebral infections and primitive
obstetric services common in developing countries add to the
burden of epilepsy [6–8].
Although the prevalence of epilepsy is slightly higher in men
than in women [9,10]. Women with epilepsy (WWE) have been
shown to have peculiar issues regarding management [11]. The
burden of epilepsy is not well deﬁned in women in LMICs [4],
considering that a large proportion of them are within the
childbearing age [12]. This is different in high income countries
(HIC) where there is a growing concern for WWE with regards to
marriage, fertility, pregnancy, childbirth, teratogenicity, meno-
pause, and contraception [13–17]. Despite the treatment gap in
epilepsy in LMIC [18]; WWE are by far more neglected in sub-
Saharan Africa [19], with more likelihood of psychosocial distress
compared to other chronic health conditions [11,19]. Some of theserved.
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stigmatization, poor education, traditional and animistic beliefs,
and fear of teratogenic effect of antiepileptic drugs (AEDs) in
pregnancy [20–23]. These psychosocial issues often neglected are
very important that most women fail to disclose their epileptic
status, are inadequately managed and unwilling to take their
medications [21]. Pregnancy, childbirth and puerperium is a period
that requires proper management and seizure control; on the other
hand, even the inappropriate use of AEDs may have deleterious
effect on the mother and foetus [24,25].
Studies on pregnant WWE are lacking in North-east Nigeria. The
prevalence and outcome of epilepsy among pregnant women have
not previously been studied in our environment. There is also no
proper ascertainment, counselling, and treatment for pregnant
WWE in most hospitals in this region. Therefore we performed a
study to determine the prevalence of pregnant WWE, follow them
up over the course of their pregnancy; to determine the frequency
of seizure and how this affects outcome of pregnancy in women
attending antenatal clinics (ANCs) of two tertiary hospitals. This
one year prospective study will provide preliminary data and serve
as a pilot study for further multi-centre study that will provide
large information on pregnant epileptics and foetal outcome in
sub-Saharan Africa.
2. Materials and methods
2.1. Study population
This was a one year observational cohort study conducted at
two ANCs of University of Maiduguri Teaching Hospital (UMTH)
and the State Specialist Hospital (SSH) Maiduguri, Borno state,
North east Nigeria, between September 2012 and August 2013.
These two hospitals have the largest number of antenatal care
attendance in the state both for normal antenatal care and referred
cases. Subjects were consecutively recruited within an 8 month
period (September 2012–April 2013) as they attended ANC for
antenatal booking. In the recruitment process all women with
viable pregnancy underwent a 3 stage screening. The ﬁrst stage of
screening was to determine those who have had any previous
history of paroxysmal event(s) that may be suggestive of a seizure.
Secondly, subjects who have had a history of any paroxysmal event
in their lifetime were further screened to determine those who
have had at least a seizure. The third stage is to determine those
with epilepsy as deﬁned by the International League Against
Epilepsy (ILAE) as those who had 2 or more unprovoked seizure
[26]. Subjects with active epilepsy (deﬁned as those on treatment
or those who had at least a seizure within the last one year) [27],
were then recruited for the study. Most cases were ascertained
from history, and are more likely to have active ‘convulsive’
epilepsy. For most subjects, consultations were made to a family
member or friend who had witnessed the seizure episodes or their
past medical records to ascertain the nature of such paroxysmal
event(s). Those excluded from the study include; those with single
episode of seizure, seizure from a metabolic or a reversible cause,
misdiagnosed seizures as sync opal attacks, and women who have
had seizures from eclampsia either from a previous or index
pregnancy.
2.2. Instrument
We developed a standardized structured questionnaire,
adapted and modiﬁed from ‘Questionnaire for Investigation of
Epilepsy in Tropical Countries’, which was developed through
collaborative work involving the Institute of Neurological Epide-
miology and Tropical Neurology of Limoges France, the Pan-African
Association of Neurological Sciences and the ILAE, for the purposeof standardizing epilepsy study in tropical countries [28]. Medical
ofﬁcers and midwives were trained on how to ﬁll the question-
naire, perform basic examinations and follow-up the subjects. The
questionnaire consists of questions to elicit socio-demographic
characteristics (such as age, place of residence, educational
attainment, ethnic group, employment and trade), relevant
information on the index pregnancy, natural history of the seizure
disorder, clinical classiﬁcation of the seizure type based on ILAE
classiﬁcation, diagnosis of seizures and epileptic syndromes,
predisposition, risk factors, and precipitating factors of epilepsy
[26]. Both centres had experienced clinicians who were involved in
case ascertainment, supervision of the ﬁlling of questionnaires,
and assist in clinical diagnosis and classiﬁcation of epilepsy
[Questionnaire included as Supplement 1].
2.3. Treatment of pregnant epileptics
All treatments and doses received were documented. For
subjects not on AEDs, consent is sought to commence appropriate
medications if required. Common AEDs available in our hospital
are: Phenytoin, Carbamezepine, Diazepam, Phenobarbital, Primi-
done, and Valproic acid. The commonest prescribed in women
of child bearing age is Carbamezepine. Additionally, they are
routinely prescribed haematinics containing iron and folic acid.
2.4. Follow-ups and delivery
The subjects were followed-up during the course of the
pregnancy based on the ANC schedule. The conventional ANC
schedule in these hospitals starts with ANC booking at the end of
the ﬁrst trimester. They are seen every 4 weeks until 28 weeks of
gestation, then every 2 weeks until 36 weeks and weekly until
delivery. The frequency and seizure types, including treatments
were recorded during these visits, in addition to their routine
antenatal consultations.
Delivery was conducted by an obstetrician registrar or a
midwife at the labour wards of the hospitals. The method of
delivery is documented. On delivery the newborn were examined;
the APGAR score was calculated, and gestational age was
determined. Adverse outcomes of pregnancy include; Stillbirth,
foetal loss and congenital malformations. Those who had an
uneventful pregnancy, delivery, and no adverse foetal outcome
were considered to have a positive pregnancy outcome. All these
information were recorded in the questionnaire.
The subjects were encouraged to come for follow-ups and to
deliver in the designated hospitals. Telephone numbers, proper
addresses of the patient were recorded for the ease of tracking
them, since it is known that women in general and WWE may just
prefer to deliver at home under the supervision of a traditional
birth attendant [18,23].
2.5. Ethical methods
The study protocol was reviewed and approved by the Ethics
Committee of the University of Maiduguri Teaching Hospital and
the Borno State Ministry of Health. Informed consent was obtained
before a candidate is enrolled in the study. All questionnaires
written in English were interpreted into the common local
languages, Hausa and Kanuri. Trained medical personnel were
assigned to each of the designated clinics, who administered the
Informed consent and the questionnaire.
2.6. Statistical analysis
Descriptive statistics was used to analyze characteristics. A
univariate analysis was carried out using Fisher’s Exact test for
Table 1
Socio-demographic characteristics and seizure outcome.
Variables Seizures Chi square P-value





15–24years 2 (33.3) 12 (70.6) 5.218 .074
25–34years 4 (66.7) 3 (17.6)
35–44years 0 (0) 2 (11.8)
Employment
Employed 3 (50.0) 2 (11.8) 3.811 .051
Unemployed 3 (50.0) 15 (88.2)
Education
Less than primary education 6 (100) 15 (93.8) .393 .531
Primary education and more 0 (0.0) 1 (6.2)
Living area
Urban 4 (66.7) 13 (76.5) .221 .638
Semi-Urban 2 (33.3) 4 (23.5)
Ethnic groups
Kanuri 2 (33.3) 11 (64.7) 1.776 .183
Others 4 (66.7) 6 (35.3)
Family history of epilepsy
Yes 1 (16.7) 3 (17.6) .003 .957
No 5 (83.3) 14 (82.4)
Head injury
Yes 2 (33.3) 0 (0.0) 6.206 .013b
No 4 (66.7) 17 (100)
Measles
Yes 1 (16.7) 4 (23.5) .123 .726
No 5 (83.3) 13 (76.5)
Encephalopathy/encephalitis
Yes 2 (33.3) 0 (0) 6.404 .041b
No 4 (66.7) 17 (100)
Meningitis
Yes 0 (0) 1 (5.9) .369 .544
No 6 (100) 16 (94.1)
Treatment with AED
Yes 1 (16.7) 7 (41.2) 1.174 .278
No 5 (83.3) 10 (58.8)
a Seizures occurred during pregnancy.
b Statistically signiﬁcance when p < 0.05.
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the relationship between the number of seizures during pregnancy
and pregnancy outcome. A P-value of 0.05 was considered
statistically signiﬁcant. All analyses were done using the Statistical
Package for Social Sciences. SPSS Version 16.0 SPSS Inc; Chicago, IL,
USA.
3. Results
We screened a total of 7063 subjects, 5449 (77.1%) from the SSH
and 1614 (22.9%) from the UMTH. The screening process and
recruitment is summarized in Fig. 1. One hundred and eleven
subjects (1.57%) had a past history of paroxysmal event. Those who
have had at least a seizure in their lifetime irrespective of cause
were 103 (1.46%). From which 88 (1.25%) subjects were excluded
from the study; of those excluded 8 (0.11%) were diagnosed as
syncopal attacks, 2 (0.03%) had previous single seizure episode
more than ﬁve years ago and 78 (1.10%) had a past history of
seizure from eclampsia. We identiﬁed 23 (0.33%) pregnant subjects
with active convulsive epilepsy, who participated in the study. The
unadjusted prevalence of epilepsy in pregnant women was found
to be 3.33 per 1000 (95% CI: 2.1–4.8). Mean age of study
participants was 23.7  6.0 [Median 23.0 years; range 16–40 years].
The socio-demographic characteristics and seizure outcome,
between those who had seizure during pregnancy and those who
did not are shown in Table 1. There was no signiﬁcant difference
in the sociodemographic characteristic like; age groups, employ-
ment, education, living area and ethnicity, between these two
groups. Subjects who had a past history of head injury and
encephalitis were more likely to have seizures during pregnancy.
(P = 0.013 and P = 0.041) There was no difference with use of AED
in treatment between the two groups.
Seizure characteristic and pregnancy outcome in those with
positive or negative pregnancy outcome is shown the Table 2.
Those who had seizures within the last six months beforeTotal p regnant  women 
screened 7,063
[5449 (77.1%) from the SSH 
and 1614 (22.9%)  fro m the 
UMTH]
6952 subjects with no 
history of paroxysmal 




 Stage of Screenin g 
Pregnant  wo men with 
a history of 
paroxysmal  event  - 
111 (1.57%)  
2
nd
 Stage of Screenin g 8 (0.11%) subjects 
excluded diagnosed as 
syncopal attack
Subject with past 
history of  seizure  - 
103 (1.46%)
Excluded, past history of 
Seizure from eclampsia - 78 
(1.10%)
Single seizure – 2 (0.03%) 
3
rd
 Stage of Screenin g 
23 (0.33 %) subjects with 
diagnosis  of  active 
convulsive epilepsy 
recruited for the study 
Fig. 1. Screening process and recruitment.recruitment were more likely to have a negative pregnancy
outcome (P = 0.043). There were ﬁve subjects with negative
outcome of pregnancy which includes one spontaneous abortion,
one still birth, one intra-uterine foetal death, one neonatal sepsis &
one congenital malformation (hypo plastic nail). No difference
exists between the two groups regarding age of ﬁrst seizure,
seizure type, precipitants and treatment of epilepsy.
Table 3 depicts the use of AED and pregnancy outcome, showing
no signiﬁcant difference in outcome between the various AED
types. It also shows no difference between drug compliance and
pregnancy outcomes.
The relationship between seizure during pregnancy and
pregnancy outcome is shown in Table 4. This observation although
important, was not statistically signiﬁcant.
The spearman’s correlation shows that an inverse correlation
(not statistically signiﬁcant; r = 0.089; P = 0.735) exists between
number of seizures during pregnancy and pregnancy outcome,
as the number of seizures increase during pregnancy, pregnancy
outcome tends towards a negative outcome.
4. Discussions
This is the ﬁrst prospective study that examined pregnant
epileptics in Northeast Nigeria. Our study found a prevalence of
active epilepsy of 3.33 per 1000 among pregnant women. The
prevalence found in this study is lower than some studies [29,30],
but higher than the study by Artama et al. [31]. Generally epilepsy
studies reported a higher prevalence in developing countries than
what was reported in this study [5,9,32]. The reason for a lower
Table 2
Seizure characteristics and pregnancy outcome.
Variables Pregnancy outcome Chi square P-value




Age at ﬁrst seizure
12years 5 (27.8) 1 (20.0) .123 .726
>12years 13 (72.2) 4 (80.0)
Last seizure occurrence
< 6months 9 (50.0) 5 (100) 4.107 .043c
6months 9 (50.0) 0 (0)
Seizure type
Generalized seizure 14 (77.8) 5 (100) 1.345 .246
Partial seizure 4 (22.2) 0 (0)
Precipitants of seizureb
Emotion 7 (38.9) 4 (80.0) 2.65 .104
Alcohol 1 (5.6) 0 (0.0) .290 .590
Sleep 3 (16.7) 0 (0.0 .958 .328
Lack of sleep 11 (61.1) 2 (40.0) .710 .400
Flashing light 4 (22.2) 0 (0) 1.345 .246
Hyperventilation 2 (11.1) 1 (20) .273 .602
Menstruation 7 (38.9) 0 (0.0) 2.795 .095
Treatment of epilepsy
Traditional medication 7 (38.9) 1 (20.0) .713 .870
AED 6 (33.3) 2 (40.0)
AED & traditional
medication
2 (11.1) 1 (20.0)
None 3 (16.7) 1 (20.0)
a Negative outcome of pregnancy includes spontaneous abortion, still birth,
intra-uterine foetal death, neonatal sepsis & congenital malformation.
b Multiple response.
c Statistically signiﬁcance when P < 0.05.
Table 4
Relationship between seizure during pregnancy and pregnancy outcome.
Variables Pregnancy outcome Chi square P-value





No seizures 13 (72.2) 4 (80.0) .123 .726
Had seizure 5 (27.8) 1 (20.0)
M.M. Watila et al. / Seizure 26 (2015) 7–1110prevalence in this study may be due to differences in methodology.
Our study was hospital-based and included only pregnant WWE.
Community based studies generally report a higher prevalence
[33]. Women have a poor health-seeking habits in sub-Saharan
Africa which may also explain the lower prevalence [34]. Most of
our women in this study were unemployed and without formal
education, they are more likely to have limited information and
seek access to health care. Other reasons for the lower prevalence
in this study may be issues of stigmatizations [21,22], low fertility
rate [35,36], and decrease sexual interest [37]. Increase mortality,
especially in people with active convulsive epilepsy may also
contribute to the lower prevalence [38]. These could be areas for
further studies in our community.
During our screening we observed a high prevalence of
eclampsia. It is a common cause of acute symptomatic seizures
in women of reproductive age in sub-Saharan Africa; but generally
not regarded as an epileptic disorder [39,40]. Further studies need
to be conducted to determine whether it has any link or remote
relationship with subsequent long term development of epilepsy.Table 3
Use of AED and pregnancy outcome.
Variables Pregnancy outcome Chi square P-value





Barbiturate 1 (5.6) 1 (20.0) 1.028 .311
Diazepam 0 (0) 2 (40.0) 7.886 .056
Carbamazepine 5 (27.8) 3 (60.0) 1.791 .181
Phenytoin 1 (5.6) 0 (0.0) .290 .590
Valporic Acid 3 (16.7) 0 (0.0) .958 .328
AED taken regularly
Yes 6 (33.3) 2 (40.0) .077 .782
No 12 (66.7) 3 (60.0)
a multiple response.Our study showed that those with a history of head injury
and encephalitis were more likely to have persistent seizures
in pregnancy; these aetiologies are commonly associated with
seizure and epilepsy in Africa [7,41].
Those who had seizures within the last six months before
recruitment in this study were more likely to have a negative
pregnancy outcome; however we found no association between
seizure occurrence during pregnancy and pregnancy outcome. This
may suggest a relationship between long-term seizure control
on pregnancy outcome due to recurrent and cumulative effect of
recurrent seizure over a long time [42]. Our study found a non-
signiﬁcant inverse correlation between number of seizures during
pregnancy and pregnancy outcome; the small sample size might
explain the non-signiﬁcance. A larger study involving more pregnant
women with ACE is therefore warranted. A study by Chen et al. [43]
observed that epileptic seizures during pregnancy were indepen-
dently associated with increased risk of negative pregnancy outcome,
suggesting that uncontrolled seizure during pregnancy and delivery
may be associated with poor pregnancy outcome. The adverse effects
of seizures on pregnancy outcome have been reported to be due to
intrauterine haemorrhages, early abortion and still births; attribut-
able to uterine injury and placental bruising or detachment [42]. The
strength of the study is that, it is the ﬁrst in this part of the country to
examine epilepsy in a population of pregnant women. We also
screened a large number of pregnant women. This study will form a
template for further multicentre study. We observed from these ANCs
that history of epilepsy is not asked routinely as done for other
medical conditions like diabetes, hypertension and asthma.
There are several limitations in this study. Firstly, the small
sample size and the short duration of the study will affect the
statistical power of the study. This lack of power will make statistical
inferences difﬁcult and therefore giving more weight to statistical
signiﬁcance will be fraught with error. Secondly, it is a hospital-
based study. The prevalence in this study may not be the true
reﬂection of what obtains in the community, some women may not
want to disclose their epileptic status due to issues of stigmatisa-
tions and fear that if others know about their diagnosis they may
inﬂuence their husbands to abandon them [21,22]. Thirdly, being a
resource poor setting, MRI scans and EEG were not available and
therefore clinical characterization and classiﬁcation of epilepsy
could not be ascertained; this would have been useful as this study
shows a bias for reporting generalized convulsive seizure compared
to partial seizures. Fourthly, we did not include non-convulsive
epilepsies, as this is difﬁcult to ascertain in our environment. Fifthly,
our lack of consideration of serum concentration of AEDs to help give
an idea on those who are compliant to medications as most times
verbal communication may not be relied on.
These methodological limitations does not invalidate the results
as the gold standard for case ascertainment in epilepsy is still from
clinical history elicited by an experienced clinician [26].
5. Conclusion
Our study found a prevalence of active epilepsy of 3.33 per 1000
among pregnant women, with about one percent having a past
history of seizure from eclampsia. Despite the small sample size;
M.M. Watila et al. / Seizure 26 (2015) 7–11 11subjects who had a past history of head trauma and encephalitis
were more likely to have seizure during pregnancy. Those with
poor seizure control were more likely to have a negative pregnancy
outcome. This study should generate interest in pregnant WWE
in our region. We suggest that better optimization of AEDs and
control of seizure before and during pregnancy will likely improve
outcomes in pregnant epileptics.
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